• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Endo terminates $190M deal for sterile injectable player fiercepharma
    March 03, 2019
    The Dublin-based Endo and its Par sterile injectables subsidiaries Wednesday said a $190 million agreement to buy sterile injectables company Somerset Therapeutics had been terminated without penalties because it was taking too long to complete.

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service